The authors regret to inform that the Graphical Abstract, Figure 3, Scheme 2 and the general structure presented in Table 1 for structures labelled 13a-f; 15 and 16, depict the synthesized compounds as the incorrect isomer (1,5-substituted triazole instead of 1,4-substituted). Although this editing mistake is apparent to the more experienced readership, we felt it was anyway necessary to correct this point. All the compounds synthesized in this work are the 1,4-regioisomer as reported in the experimental data and reported and drawn in the supplementary material. Updated Graphical Abstract: [Formula presented] Updated Figure 3: [Formula presented] Updated Scheme 2: [Formula presented] Updated Table1: [Table presented]

Corrigendum to “Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors” [Eur. J. Med. Chem. 101 (2015) 573–583] (European Journal of Medicinal Chemistry (2015) 101 (573–583), (S0223523415301434), (10.1016/j.ejmech.2015.07.011)) / de Lucia, D.; Lucio, O. M.; Musio, B.; Bender, A.; Listing, M.; Dennhardt, S.; Koeberle, A.; Garscha, U.; Rizzo, R.; Manfredini, S.; Werz, O.; Ley, S. V.. - In: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0223-5234. - 103:(2015), pp. 223-225. [10.1016/j.ejmech.2015.08.050]

Corrigendum to “Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors” [Eur. J. Med. Chem. 101 (2015) 573–583] (European Journal of Medicinal Chemistry (2015) 101 (573–583), (S0223523415301434), (10.1016/j.ejmech.2015.07.011))

de Lucia D.;Musio B.;Rizzo R.;
2015-01-01

Abstract

The authors regret to inform that the Graphical Abstract, Figure 3, Scheme 2 and the general structure presented in Table 1 for structures labelled 13a-f; 15 and 16, depict the synthesized compounds as the incorrect isomer (1,5-substituted triazole instead of 1,4-substituted). Although this editing mistake is apparent to the more experienced readership, we felt it was anyway necessary to correct this point. All the compounds synthesized in this work are the 1,4-regioisomer as reported in the experimental data and reported and drawn in the supplementary material. Updated Graphical Abstract: [Formula presented] Updated Figure 3: [Formula presented] Updated Scheme 2: [Formula presented] Updated Table1: [Table presented]
2015
Corrigendum to “Design, synthesis and evaluation of semi-synthetic triazole-containing caffeic acid analogues as 5-lipoxygenase inhibitors” [Eur. J. Med. Chem. 101 (2015) 573–583] (European Journal of Medicinal Chemistry (2015) 101 (573–583), (S0223523415301434), (10.1016/j.ejmech.2015.07.011)) / de Lucia, D.; Lucio, O. M.; Musio, B.; Bender, A.; Listing, M.; Dennhardt, S.; Koeberle, A.; Garscha, U.; Rizzo, R.; Manfredini, S.; Werz, O.; Ley, S. V.. - In: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0223-5234. - 103:(2015), pp. 223-225. [10.1016/j.ejmech.2015.08.050]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11589/223795
Citazioni
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact